1. See more
    See more
    See all on Wikipedia
    See more
    Wikipedia
    https://en.wikipedia.org/wiki/Ibalizumab

    Ibalizumab - Wikipedia

    Ibalizumab, sold under the brand name Trogarzo, is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to … See more

    Medical uses

    Ibalizumab, in combination with other antiretrovirals, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) … See more

    External links

    • "Ibalizumab". Drug Information Portal. U.S. National Library of Medicine. See more

    Development

    Ibalizumab is being developed by TaiMed Biologics but was originally developed by Tanox, now part of Genentech. As part of Genentech's takeover of Tanox, the patent for ibalizumab was sold to TaiMed Biologics, a biotech company formed in 2007 with support … See more

    From Wikipedia
    From Wikipedia
    Content
    Medical uses
    Development
    External links
    See all sections
    Wikipedia text under CC-BY-SA license
    Feedback
  2. The New England Journal of Medicine
    https://www.nejm.org/doi/full/10.1056/NEJ…

    Phase 3 Study of Ibalizumab for Multidrug-Resistant …

    Aug 15, 2018 · Ibalizumab, a humanized IgG4 monoclonal antibody, blocks the entry of human immunodeficiency virus type 1 (HIV-1) by noncompetitive …

    • Author: Brinda Emu, Jeffrey Fessel, Shannon Schrader, Princy Kumar, Gary Richmond, Sandra Win, Steven Weinhe...
    • Publish Year: 2018
  3. TROGARZO®
    https://trogarzo.com

    TROGARZO®

  5. PubMed
    https://pubmed.ncbi.nlm.nih.gov/31970712

    Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection

  6. PubMed
    https://pubmed.ncbi.nlm.nih.gov/32659101

    Ibalizumab: The First Monoclonal Antibody for the Treatment of

  7. Explore Ibalizumab

  8. National Center for Biotechnology Information
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988774

    Ibalizumab: First Global Approval - PMC - National Center for ...

  9. DrugBank Online
    https://go.drugbank.com/drugs/DB12698

    Ibalizumab: Uses, Interactions, Mechanism of Action - DrugBank …

  10. Drugs.com
    https://www.drugs.com/mtm/ibalizumab.html

    Ibalizumab Uses, Side Effects & Warnings - Drugs.com

  11. The New England Journal of Medicine
    https://www.nejm.org/doi/full/10.1056/NEJMp1808729

    Ibalizumab in Multidrug-Resistant HIV — Accepting Uncertainty

  12. National Center for Biotechnology Information
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899216

    Efficacy, Pharmacokinetics, and Safety Over 48 Weeks With …